A potent synthetic vasopressin analogue for intravenous use. Primarily indicated for the management of Hepatorenal Syndrome (HRS) by causing selective splanchnic vasoconstriction.

A recombinant human growth hormone (somatropin) for subcutaneous administration. Indicated for growth hormone deficiency in children and adults, as well as short stature conditions.

A recombinant human erythropoietin indicated to stimulate red blood cell production. Used in the management of anemia associated with chronic kidney disease and chemotherapy.

A once-weekly subcutaneous injection that supports blood sugar control and weight management. Works as a GLP-1 receptor agonist to regulate insulin secretion and reduce appetite.